StockData
SpyGlass Pharma, Inc. logo

SpyGlass Pharma, Inc. (SGP) income statement

SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$30.43−0.35 (-1.14%)

Close on Nov 20, 2026Market cap $1.02BP/E –Yield –

See a number that looks wrong?